Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
| Business Activity | PASS |
| Debt Ratio | N/A |
| Cash Ratio | N/A |
| Receivables Ratio | N/A |
| Revenue Ratio | N/A |
| Overall | INSUFFICIENT DATA |
$1.7B
6.12
-2.335
13
$738.9K
1.38
1.60
0.0%
134
| Shares | Cost | Profit to Target | R:R |
|---|---|---|---|
| To Consensus ($46.59, 13 analysts) | |||
| 10 | $294.70 | +$171.20 (58%) | 3.9R |
| 50 | $1,473.50 | +$856.00 (58%) | 3.9R |
| 100 | $2,947.00 | +$1,712.00 (58%) | 3.9R |
- No elevated risk flags in current data
A single score combining all analytical layers below. A is strongest, D is weakest.
How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.
Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.
What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?
Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.
Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.
These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.
| Ticker | Correlation |
|---|---|
| MPLT | 0.333 |
| MGTX | 0.308 |
| SYRE | 0.285 |
| SNDX | 0.282 |
| IDYA | 0.281 |
| Ticker | Correlation |
|---|---|
| ALEC.AE | -0.252 |
| ALFIRDOUS.AE | -0.172 |
| ENGRO.KA | -0.162 |
| PRN.L | -0.148 |
| ITHMR.AE | -0.125 |
Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.
How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.